Information Provided By:
Fly News Breaks for February 13, 2019
JNJ, ISRG
Feb 13, 2019 | 10:55 EDT
Piper Jaffray analyst JP McKim reiterated an Overweight rating on Intuitive Surgical (ISRG) following this morning's announcement that Johnson & Johnson (JNJ) will buy Auris Health, with "robotics visionary" Dr. Fred Moll joining J&J upon completion of the deal. In a research note to investors, McKim says the deal doesn't really change his thesis on Intuitive Surgical, and believes the price J&J is paying "shows investors how much they should be valuing ISRG's Ion platform."
News For ISRG;JNJ From the Last 2 Days
JNJ
JNJ
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.